-
Loading metrics
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
- Akiho Fukuda,
- Kohei Tahara,
- Yuuki Hane,
- Toshinobu Matsui,
- Sayaka Sasaoka,
- Haruna Hatahira,
- Yumi Motooka,
- Shiori Hasegawa,
- Misa Naganuma,
- Junko Abe
x
- Published: September 27, 2017
- https://doi.org/10.1371/journal.pone.0185654